Functional Genomic Screening Identifies lncRNA CNPY2-AS1 as a Regulator of Redox Metabolism and Antiviral Immunity
Carolina Khoury, Tahleel Ali-Nasser, Yuval Ben Eliahu, Haya Dahamshy Silawi, Liran Ben Yaakov, Simon Rousseau, Yvan Devaux, Nisrine Lahoud-Jeries, Assaf C Bester · 2026
Read Functional Genomic Screening Identifies lncRNA CNPY2-AS1 as a Regulator of Redox Metabolism and Antiviral Immunity by Carolina Khoury, Tahleel Ali-Nasser, Yuval Ben Eliahu, Haya Dahamshy Silawi, Liran Ben Yaakov, Simon Rousseau, Yvan Devaux, Nisrine Lahoud-Jeries, Assaf C Bester (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13618004.txt.
Description
Nine authors, led by Carolina Khoury, report a 2026 study that screened the genome for long non-coding RNAs that shape defense against viruses. These RNAs do not build proteins, yet they guide many cell processes. Their roles in viral entry, the first step of infection, were still poorly known.
The team used a genome-wide CRISPR screen to find such RNAs that change how SARS-CoV-2 gets into cells. Two hits stood out. One locus acts on nearby genes linked to viral entry and to COVID-19 severity. The other, called CNPY2-AS1, works across the cell. Loss of that RNA upsets redox balance, the cell's control of reactive oxygen species. That loss switches on immune signals even without a trigger, and one switched-on gene limits viral entry by lowering ACE2 on the cell surface.
Catalog record
| CREATOR | Carolina Khoury, Tahleel Ali-Nasser, Yuval Ben Eliahu, Haya Dahamshy Silawi, Liran Ben Yaakov, Simon Rousseau, Yvan Devaux, Nisrine Lahoud-Jeries, Assaf C Bester |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |